ENTITY

Tg Therapeutics (TGTX US)

2
Analysis
Health CareUnited States
TG Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of innovative pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. Currently, the company is developing two therapies targeting hematological malignancies, specifically, relapsed and refractory non-Hodgkins lymphoma.
more
bullishTg Therapeutics
11 Jul 2024 19:52Syndicated

Tg Therapeutics Inc (TGTX) - Thursday, Apr 11, 2024

TG Therapeutics focuses on developing treatments for B-cell mediated diseases, including their flagship product Briumvi for Multiple Sclerosis The...

Logo
197 Views
Share
08 Sep 2024 11:54

S&P500/400/600 Index Rebalance: Dell, Palantir Make It (Finally!); Apple Upweight

There are 3 changes for the SnP500, 8 for the SnP400 and 15 for the SnP600 Index. Dell and Palantir have finally been added. There is huge size to...

Logo
546 Views
Share
No more insights
x